Picard Medical (PMI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
19 Feb, 2026Executive summary
A special meeting of stockholders is scheduled for March 10, 2026, to be held entirely online, with voting available via internet, phone, or mail.
The main purpose is to consider and vote on an amendment to increase authorized capital stock from 180,000,000 to 330,000,000 shares, including an increase in common stock from 150,000,000 to 300,000,000.
The Board unanimously recommends voting in favor of the amendment, citing the need for flexibility in raising capital and meeting existing obligations.
Voting matters and shareholder proposals
The sole proposal is to amend the Certificate of Incorporation to increase authorized shares of capital stock and common stock.
Stockholders of record as of February 6, 2026, are entitled to vote, with each share of common stock entitled to one vote.
The Board recommends a vote FOR the proposal.
Approval requires a majority of shares present or represented by proxy and entitled to vote.
Abstentions count as votes against; broker non-votes have no effect.
Board of directors and corporate governance
The Board retains discretion to abandon the amendment even after stockholder approval if deemed not in the best interests of the company.
The Board and management are authorized to vote on other matters that may arise at the meeting.
Latest events from Picard Medical
- Approval sought for major share increase and new issuances to enable financing and NYSE compliance.PMI
Proxy Filing19 Feb 2026 - Shareholders to vote on doubling authorized common stock to enable future growth and flexibility.PMI
Proxy Filing10 Feb 2026 - FDA-approved artificial heart maker registers 17M shares for resale amid ongoing losses and risks.PMI
Registration Filing4 Feb 2026 - Market leader advances total artificial heart tech, targeting global growth and next-gen innovation.PMI
H.C. Wainwright 27th Annual Global Investment Conference3 Feb 2026 - Resale of up to 17M shares may dilute holders as company seeks growth in artificial heart market.PMI
Registration Filing12 Jan 2026 - Vote to expand the equity plan and add warrants, supporting long-term talent retention.PMI
Proxy Filing2 Dec 2025 - Vote sought to expand equity plan to 18M shares and add warrants to attract and retain talent.PMI
Proxy Filing2 Dec 2025 - FDA-approved artificial heart leader seeks IPO to fund R&D, China JV, and address liquidity.PMI
Registration Filing29 Nov 2025 - FDA-approved artificial heart leader seeks IPO to fund R&D and global expansion amid ongoing losses.PMI
Registration Filing29 Nov 2025